[go: up one dir, main page]

AU2240492A - Sequences characteristic of human gene transcription product - Google Patents

Sequences characteristic of human gene transcription product

Info

Publication number
AU2240492A
AU2240492A AU22404/92A AU2240492A AU2240492A AU 2240492 A AU2240492 A AU 2240492A AU 22404/92 A AU22404/92 A AU 22404/92A AU 2240492 A AU2240492 A AU 2240492A AU 2240492 A AU2240492 A AU 2240492A
Authority
AU
Australia
Prior art keywords
human gene
gene transcription
transcription product
sequences characteristic
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22404/92A
Inventor
Mark D Adams
J. Craig Venter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
Government of the United States of America
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Government of the United States of America filed Critical Government of the United States of America
Publication of AU2240492A publication Critical patent/AU2240492A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU22404/92A 1991-06-20 1992-06-19 Sequences characteristic of human gene transcription product Abandoned AU2240492A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US71683191A 1991-06-20 1991-06-20
US716831 1991-06-20
US83719592A 1992-02-12 1992-02-12
US837195 1992-02-12

Publications (1)

Publication Number Publication Date
AU2240492A true AU2240492A (en) 1993-01-25

Family

ID=27109605

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22404/92A Abandoned AU2240492A (en) 1991-06-20 1992-06-19 Sequences characteristic of human gene transcription product

Country Status (3)

Country Link
EP (1) EP0593580A4 (en)
AU (1) AU2240492A (en)
WO (1) WO1993000353A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3560252B2 (en) * 1992-08-28 2004-09-02 アベンティス ファーマ株式会社 Bone-related cadherin-like protein and method for producing the same
JPH09508800A (en) * 1994-02-14 1997-09-09 スミスクライン・ビーチャム・コーポレイション Method for identifying differentially expressed genes
US5834248A (en) * 1995-02-10 1998-11-10 Millennium Pharmaceuticals Inc. Compositions and methods using rchd534, a gene uregulated by shear stress
US5866330A (en) 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5695937A (en) * 1995-09-12 1997-12-09 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
AU4105396A (en) 1995-11-02 1997-05-29 Human Genome Sciences, Inc. Mammary transforming protein
US5936078A (en) * 1995-12-12 1999-08-10 Kyowa Hakko Kogyo Co., Ltd. DNA and protein for the diagnosis and treatment of Alzheimer's disease
CN1173896A (en) * 1995-12-12 1998-02-18 协和发酵工业株式会社 New DNA, new peptides and new antibodies
EP0904277A4 (en) * 1996-02-16 2003-01-22 Millennium Pharm Inc Compositions and methods for the treatment and diagnosis of cardiovascular disease
US5858378A (en) * 1996-05-02 1999-01-12 Galagen, Inc. Pharmaceutical composition comprising cryptosporidium parvum oocysts antigen and whole cell candida species antigen
US6010878A (en) 1996-05-20 2000-01-04 Smithkline Beecham Corporation Interleukin-1 β converting enzyme like apoptotic protease-6
US6890721B1 (en) 1996-05-20 2005-05-10 Human Genome Sciences, Inc. Interleukin-1β converting enzyme like apoptotic protease-6
AU1931599A (en) * 1997-12-19 1999-07-12 Zymogenetics Inc. Angiopoietin homolog, dna encoding it, and method of making it
WO1999067382A2 (en) * 1998-06-24 1999-12-29 Compugen Ltd. Angiopoietin-like growth factor sequences
WO2000012525A1 (en) 1998-08-27 2000-03-09 Quark Biotech, Inc. Sequences characteristic of hypoxia-regulated gene transcription
US7544772B2 (en) 2001-06-26 2009-06-09 Biomarck Pharmaceuticals, Ltd. Methods for regulating inflammatory mediators and peptides useful therein
ES2230078T3 (en) * 1999-02-24 2005-05-01 North Carolina State University PROCEDURES AND COMPOSITIONS TO ALTERNATE THE MUCUS SECRETION.
US8501911B2 (en) 1999-02-24 2013-08-06 Biomarck Pharmaceuticals, Ltd Methods of reducing inflammation and mucus hypersecretion
US7919469B2 (en) 2000-02-24 2011-04-05 North Carolina State University Methods and compositions for altering mucus secretion
US7265088B1 (en) 2000-02-24 2007-09-04 North Carolina State University Method and compositions for altering mucus secretion
WO2002063009A2 (en) * 2001-02-02 2002-08-15 Eli Lilly And Company Lp mammalian proteins; related reagents
US7524926B2 (en) 2005-01-20 2009-04-28 Biomarck Pharmaceuticals, Ltd. Mucin hypersecretion inhibitors and methods of use
ZA200900550B (en) 2006-07-26 2010-03-31 Biomarck Pharmaceuticals Ltd Methods for attenuating release of inflammatory mediators and peptides useful therein
WO2020257162A1 (en) 2019-06-17 2020-12-24 Biomarck Pharmaceuticals Ltd. Peptides and methods of use thereof in treating uveitis

Also Published As

Publication number Publication date
WO1993000353A1 (en) 1993-01-07
EP0593580A4 (en) 1995-12-06
EP0593580A1 (en) 1994-04-27

Similar Documents

Publication Publication Date Title
AU3665893A (en) Sequences characteristic of human gene transcription product
AU2240492A (en) Sequences characteristic of human gene transcription product
AU4106193A (en) Inflatable sheath for introduction of ultrasonic catheter
AU649117B2 (en) Catalysts and process for the manufacture of vinyl acetate
AU7867994A (en) Hemofiltration of mediator-related diseases
AU6614696A (en) Inhibition of gene expression
AU1429692A (en) Pasta product and method of making same
AU6614596A (en) Inhibition of gene expression
AU1205892A (en) Novel plasmid pbul1 derived from lactobacillus and derivative thereof
AU2861892A (en) Astrocyte-specific transcription of human genes
EP0731647A4 (en) Treatment of an edible product with humectants
AU6040296A (en) Methods of inducing bef-1 transcription factor
AU3362293A (en) Control of gene transcription
AU7719791A (en) Therapeutic product
AU2548095A (en) Human inhibitor of apoptosis gene 1
AU4641393A (en) Use of mtr gene sequences for expression of foreign genes
AU672019B2 (en) Method of integrating gene into chromosome of (lactobacillus delbrueckii) species and product of gene integration
AU3130893A (en) Membrane expression of heterologous genes
AU4489196A (en) Novel medical use of heme products
AU3255093A (en) An edible product and process of preparing same
AU8007094A (en) High pressure treatment of food
AU4550089A (en) Ultraviolet stabilisation of acrylic polymers
AU2545992A (en) Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them, and their use
AU7834994A (en) Therapeutic use of the retinoblastoma susceptibility gene product
AU6997396A (en) An article of headgear